Inve India ▾

Dr Agarwals Eye Hospital share price & results

Dr Agarwals Eye Hospital Limited· Healthcare

Results to
Jun 2026
Ownership as of
Sept 2026

Leading eye care hospital chain built around Tamil Nadu, offering cataract, retina and refractive surgery plus opticals.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue143 ₹ crore+22.2% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin30.0 %−2.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit23.0 ₹ crore+35.3% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity26.98 %−5.3 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin10.19 %+12.5 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)20.05 %−5.8 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Price

₹5,250 +0.23% · +₹12.05

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −2.1% 1Y

₹4.5k₹5.0k₹5.5kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26

1Y: ₹5,360.35 on 24 Oct 2025 → ₹5,250. High ₹5,758.8 (1 Dec 2025), low ₹4,474.55 (6 Mar 2026).

Previous close
₹5,237.95
Market cap
₹2.4k Cr
52-week range
₹4,474.55 – ₹5,758.8
One year
+1.38%
Price to earnings (TTM to Jun 2026)
32.57×
Return on equity (TTM to Jun 2026)
26.98%

Overview

Symbol
NSE:DRAGARWQ
Exchange
NSE
Currency
INR

What Dr Agarwals Eye Hospital Limited does

Based on the company's own presentations, annual report and earnings calls.

Dr. Agarwal's Eye Hospital Limited operates a chain of eye care hospitals and clinics predominantly across Tamil Nadu, providing cataract, refractive, corneal, vitreo-retinal and other ophthalmic surgeries alongside consultations, diagnostics and non-surgical treatments. It also earns from selling opticals, contact lenses, accessories and eye-care pharmaceutical products through the same facility network. The company runs an asset-light, leased-premises, hub-and-spoke model with Centres of Excellence anchoring tertiary care and smaller primary/secondary facilities feeding patients into them. It is a subsidiary of promoter entity Dr. Agarwal's Health Care Limited (AHCL), which holds a 71.9% stake, and a scheme to merge the two into a single listed entity was approved by the boards in August 2025.

Segments

  • Surgeries
  • Opticals, contact lenses, accessories & pharmaceutical products
  • Diagnosis, consultations & others
Total facilities
63 (as of June 2025)
Facility mix
32 Primary, 29 Secondary, 2 Tertiary (Q1 FY26)
Doctors
230+
Paramedics
475+
Patients served (FY25)
588,000+
Surgeries performed (FY25)
62,000+
Founded 1994Headquarters Chennai, Tamil Nadu, India Company website

Your own record

Start an Inve Case for Dr Agarwals Eye Hospital Limited

Free account: one company. Everything above stays public.

Write why you follow Dr Agarwals Eye Hospital Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Healthcare companies

All Healthcare companies → · Healthcare earnings growth →

Learn to analyse Dr Agarwals Eye Hospital Limited

Guides on how to read this kind of business and the numbers that matter.